TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy

Details for Australian Patent Application No. 2006311475 (hide)

International Classifications

Event Publications

22 May 2008 PCT application entered the National Phase

PCT publication WO2007/056540 Priority application(s): WO2007/056540

19 February 2009 Alteration of Name

The name of the applicant has been altered to Medarex, Inc.; The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services

21 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.